The rapid renal clearance of penicillin has made it difficult to maintain blood levels adequate to combat resistant organisms such as enterococci and many staphylococci. Diodrast (1), p-amino-hippurate (PAH) (2) , benzoic acid (3), sodium benzoate (3, 4) , and carinamide (5), have been found to block renal tubular excretion of penicillin with enhancement of blood levels. Of these compounds, only carinamide has had wiedspread clinical use (6) (7) (8) . Its value has been limited because the large doses required make it unwieldy and often poorly tolerated (9) . This disadvantage appears to have been overcome by the recent discovery of a new compound, Benemid (10),1 which is apparently effective in low doses, and in preliminary studies has been found to have little toxicity (11) . This report is based on measurements of penicillin blood levels in 74 patients treated with intramuscular penicillin G or its procaine salt.
MATERIALS AND METHODS
The subjects studied were adult patients in the King County Hospital who were receiving penicillin for a wide variety of infections. Patients with renal disease or congestive heart failure were excluded. After control penicillin levels were obtained, Benemid was administered in doses of 0.5 gm. every six hours for at least 12 to 24 hours prior to the measurement of the post-Benemid serum levels. Diet, salt, and fluid intake were not controlled. The concentrations of penicillin in the serum were de-' Sharp and Dohme's trade name for p,-(di-n-propylsulfamyl) -benzoic acid.
termined by a tube dilution method, using killing of a Group A hemolytic streptococcus as the endpoint (12) .
CALCULATIONS OF DATA OBTAINED
Two methods were used to compute the increase in the penicillin levels after Benemid. The first method consisted of determining the increase found in each individual patient, and from these figures the average individual fold increase was calculated. The second method consisted of averaging all of the pre-and post-Benemid penicillin levels before computing the fold increase.
Average of individual fold increases: For each patient the fold increase of the serum penicillin level after Benemid was determined by dividing the post-Benemid level by the pre-Benemid level. These individual fold increases were then averaged. In a few instances there was a decrease rather than an increase following Benemid, and these fold decreases were subtracted from the total of the increases before dividing by the total number of patients.
Fold increase of the average levels: Serum penicillin levels before and after Benemid were averaged separately. The fold increase of the average levels was then determined by dividing the post-Benemid average by the preBenemid average.
RESULTS
The first group (Table I) consisted of 19 patients who were receiving 300,000 units of procaine penicillin once daily. Levels before and after Benemid were measured on one occasion in each patient at three, 12 and 24 hours following a penicillin injection. Of the 57 occasions on which concentrations were determined before and after Benemid, there was an increase in the penicillin Benemid.
The third group consisted with 600,000 units of pro than the fold increase of the average levels (2.98).
The significance of this difference will be men- The fifth group (Table IV) were not invariably higher after Benemid administration. The least favorable results from this standpoint were obtained with procaine penicillin (300,000 units) injected once daily, in which an elevation occurred in only 68% of the instances.
When procaine penicillin was administered twice daily, elevations occurred in 92%, and with aqueous penicillin administered every three hours, enhancement was recorded in 95% of cases. The marked variability in absorption of penicillin, especially the procaine salt, undoubtedly accounts for these results, and it is not surprising that the greatest inconsistencies occurred when penicillin was injected only once daily.
In the present report, the enhancement of penicillin levels has been expressed mathematically in two ways, as the average of the individual fold increases, and as the fold increase of the average levels. Disparities between these two figures occurred in all major groups studied, and are a reflection of the marked variability of penicillin levels obtained in different patients. In any one patient, the results are usually fairly constant from day to day, but even under these circumstances there is enough variability in absorption to produce marked discrepancies. A good example occurred in Group 4, in which the average of the individual fold increases (5.32) was considerably higher than the fold increase of the average levels (2.98). Here, the exclusion of only one patient, whose pre-and post-Benemid penicillin levels were 4 and 10 units respectively, would have so altered the results that with both methods of calculation the final figure would have been approximately 5.3. The average of the individual fold increases would appear to be the most valid method of expressing the results, since it indicates the increment in levels in each patient. This point has seemed worthy of emphasis since it is not universally realized that there is a great variability in penicillin levels from patient to patient.
The administration of Benemid will probably contribute little to penicillin therapy in the majority of infections caused by penicillin sensitive organisms. However, there are certain conditions in which it may prove of great value in bringing about a favorable response, and in reducing the cost of treatment. Subacute bacterial endocarditis, especially when caused by penicillin resistant organisms such as enterococci, is one of the diseases in which a great deal may be accomplished by Benemid administration. Large amounts of penicillin are required to maintain levels as high as 20 units/cc. With Benemid, such levels may be elevated to 40 or 80 units/cc. without increasing the dosage of penicillin. In some cases this will undoubtedly bring about effective therapy, and will at the same time minimize the mechanical and economic problems of massive penicillin therapy. Infections with other penicillin resistant organisms, such as staphylococci and certain of the gram negative bacilli, also fall into this category. In the patients who received Benemid in addition to 1,000,-000 units of crystalline penicillin every two hours, the blood levels were never lower than 40 units/cc. Concentrations of this magnitude should be effective in the therapy of certain infections which are not ordinarily considered susceptible to penicillin.
The results obtained in the four patients with meningitis were of special interest. Spinal fluid penicillin concentrations were elevated 10 to 40 fold in patients treated by the intramuscular route alone. The clinical response in these patients was striking, especially in a 43 year old woman who was seriously ill with staphylococcal meningitis. Benemid given in conjunction with large intramuscular doses of penicillin would appear highly efficacious in treating meningitis due to gram positive bacteria.
Finally, Benemid may find an important place in conjunction with oral penicillin therapy. The effectiveness of Benemid in prolonging therapeutic concentrations of penicillin should make it possible to achieve results with smaller doses, or with administration at greater intervals.
SUMMARY AND CONCLUSIONS
The effect of the oral administration of 0.5 gm.
of Benemid every six hours on serum penicillin levels was measured in 74 patients. In 51 patients treated with procaine penicillin, there was enhancement of penicillin levels following Benemid in 81 % of the instances, with an average fold increase of 2.87. In 23 patients treated with crystalline penicillin the levels were higher in 96%o of the cases, with an average fold increase of 5.10. This three to five fold enhancement of penicillin levels should make the therapy of certain penicillin resistant infections considerably less expensive, and simpler from a mechanical standpoint.
